Tag Archives: SIPO

Court Decision in China Recognizes Novelty in Dosage Limitations in Swiss-Form Claims

Peksung Intellectual Property Ltd sent an interesting article (link below) reporting that the Higher People’s Court of Beijing held that both dosage form and dosage amount should be treated as limitations in Swiss-form claims. These “administration-related features” are often ignored … Continue reading

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment